314 related articles for article (PubMed ID: 10483230)
1. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a bi-layer wound dressing for burn care. II. In vitro and in vivo bactericidal properties.
Martineau L; Shek PN
Burns; 2006 Mar; 32(2):172-9. PubMed ID: 16455202
[TBL] [Abstract][Full Text] [Related]
3. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
Barnea Y; Carmeli Y; Neville LF; Kahel-Reifer H; Eren R; Dagan S; Navon-Venezia S
Burns; 2009 May; 35(3):390-6. PubMed ID: 18951715
[TBL] [Abstract][Full Text] [Related]
4. The establishment of a Pseudomonas aeruginosa-infected burn-wound sepsis model and the effect of imipenem treatment.
Barnea Y; Carmeli Y; Kuzmenko B; Gur E; Hammer-Munz O; Navon-Venezia S
Ann Plast Surg; 2006 Jun; 56(6):674-9. PubMed ID: 16721084
[TBL] [Abstract][Full Text] [Related]
5. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
Moroz AF; Kharitonova AM; Chanturiia TsK
Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
[TBL] [Abstract][Full Text] [Related]
6. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
[TBL] [Abstract][Full Text] [Related]
7. [The local effect of a silver chelate on standardized scald wounds of the rat].
Springorum HW; Bertram E; Köhnlein HE; Winckler S
Arzneimittelforschung; 1975 Nov; 25(11):1782-3. PubMed ID: 812507
[TBL] [Abstract][Full Text] [Related]
8. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns.
Hosseini SV; Tanideh N; Kohanteb J; Ghodrati Z; Mehrabani D; Yarmohammadi H
Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910
[TBL] [Abstract][Full Text] [Related]
9. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
[TBL] [Abstract][Full Text] [Related]
10. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
Ziółkowski G; Dudzińska G; Sakiel S
Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
[No Abstract] [Full Text] [Related]
11. Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression.
Bielecki P; Glik J; Kawecki M; Martins dos Santos VA
Biotechnol Lett; 2008 May; 30(5):777-90. PubMed ID: 18158583
[TBL] [Abstract][Full Text] [Related]
12. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
13. The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
Drake DJ; Froese EH
Cent Afr J Med; 1975 Apr; 21(4):71-2. PubMed ID: 806345
[No Abstract] [Full Text] [Related]
14. [Treatment of Pseudomonas aeruginosa infection in burn patients].
Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
[No Abstract] [Full Text] [Related]
15. Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections.
Fu KP; Vince T; Hung PP; Gregory JF
Drugs Exp Clin Res; 1986; 12(4):303-6. PubMed ID: 3720518
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced infection. An in vivo study.
Hashimoto MC; Prates RA; Kato IT; Núñez SC; Courrol LC; Ribeiro MS
Photochem Photobiol; 2012; 88(3):590-5. PubMed ID: 22404212
[TBL] [Abstract][Full Text] [Related]
17. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
Valdéz JC; Peral MC; Rachid M; Santana M; Perdigón G
Clin Microbiol Infect; 2005 Jun; 11(6):472-9. PubMed ID: 15882197
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
19. Protamine sulfate reduces the susceptibility of thermally injured mice to Pseudomonas aeruginosa infection.
Haynes A; Rumbaugh KP; Park PW; Hamood AN; Griswold JA
J Surg Res; 2005 Jan; 123(1):109-17. PubMed ID: 15652958
[TBL] [Abstract][Full Text] [Related]
20. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004.
Messadi AA; Lamia T; Kamel B; Salima O; Monia M; Saida BR
Burns; 2008 Dec; 34(8):1098-102. PubMed ID: 18619737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
